Not Yet RecruitingPhase 1ACTRN12605000051640
A safety study of autologous mesenchymal precursor cells (MPCs) in the management of delayed healing tibial fractures requiring secondary surgical intervention to promote fracture union.
A safety study of autologous mesenchymal precursor cells in the management of delayed healing tibial fractures requiring secondary surgical intervention to promote fracture union.
Sponsor
Mesoblast
Enrollment
10 participants
Start Date
Aug 3, 2006
Study Type
Interventional
Conditions
Eligibility
Sex: Both males and females
Inclusion Criteria1
- A tibial fracture that is either delayed or a non-union that is classified according to the Association of Osteosynthesis as either 42-A, 42-B or 42-C
Exclusion Criteria1
- A wound associated with the fracture that is classified according to the Gustilo Anderson Classification System as a IIIC
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Surgery and administration of MPCs
Surgery and administration of MPCs
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000051640